Table 3 Correlation between the clinical characteristics and Sp1 expression in NPC patients

Age (y)

≤ 45

18 (54.5%)

16 (37.2%)

0.165

> 45

15 (45.5%)

27 (62.8%)

Gender

Male

24 (72.7%)

31 (72.1%)

1.01

Female

9 (27.3%)

12 (27.9%)

Clinical stage

I-II

18 (54.5%)

6 (14%)

0.00036

III-IV

15 (45.5%)

37 (86.0%)

T classification

T1-T2

22 (66.7%)

13 (30.4%)

0.002

T3-T4

11 (33.3%)

30 (69.6%)

N classification

N0-N1

25 (75.8%)

22 (51.2%)

0.034

N2-3

8 (24.2%)

21 (48.8%)

Metastases

No

33 (100%)

41 (95.3%)

0.502

Yes

0

2 (4.7%)

NKUC

31 (93.9%)

43 (100%)

0.185

NKDC

2 (6.1%)

0

Fisher’s exact test